Correlative Imaging : Stomach cancer(TEIN Lecture Series 2022 2nd)

Value of the Information & Strength of the Argument

The lecture provides valuable information on the use of correlative imaging in stomach cancer, integrating anatomical, pathological, and imaging findings. The argumentation is solid, based on established staging systems and clinical experience. The speaker explains the rationale behind imaging findings, such as the relationship between FDG uptake and histology, and the importance of considering physiologic uptake. The use of clinical cases illustrates the practical application and limitations of imaging. The lecture is well-structured and informative for medical professionals.

Scientific Rigor, Source Quality, Title Accuracy

The lecture demonstrates scientific rigor by referencing the AJCC 8th edition staging system and discussing recent molecular subtypes (EBV, MSI) with potential FDG uptake correlations. However, specific studies are not cited in the lecture, and the description provides no links. The title accurately reflects the content, focusing on correlative imaging in stomach cancer. The lecture is delivered by an expert from a reputable institution, enhancing credibility. No comments were provided for analysis.

The title accurately reflects the content, which focuses on correlative imaging (CT, FDG PET) in the staging and management of stomach cancer.

8/10

The lecture is delivered by a specialist in nuclear medicine, likely from Seoul National University, a reputable institution. The content is based on established staging systems (AJCC 8th edition) and includes clinical cases, but lacks explicit citations to specific studies. The information is consistent with current medical knowledge.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction to the lecture series and today's topic on stomach cancer.
• 05:00Epidemiology of stomach cancer, highlighting high incidence in Asia.
• 10:00Anatomy of the stomach and the five layers of the gastric wall.
• 15:00CT imaging for T-staging, including normal wall thickness and distention.
• 20:00AJCC 8th edition T-staging criteria and the role of ligaments in tumor spread.
• 25:00FDG PET physiology and uptake patterns in the stomach.
• 30:00Histology-related FDG uptake: intestinal vs. diffuse types.
• 35:00Case 1: Poorly differentiated carcinoma with low FDG uptake.
• 40:00Case 2: Intestinal-type adenocarcinoma with high FDG uptake and nodal metastases.
• 45:00Lymph node staging: CT criteria and limitations of FDG PET.
• 50:00Distant metastases and the role of FDG PET in upstaging.
• 55:00Peritoneal carcinomatosis: low sensitivity of FDG PET, importance of CT.
• 1:00:00Case 3: Peritoneal infiltration and diffuse gastric cancer.